188 related articles for article (PubMed ID: 6931258)
1. Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays.
Blazar BA; Laing CA; Miller FR; Heppner GH
J Natl Cancer Inst; 1980 Aug; 65(2):405-10. PubMed ID: 6931258
[TBL] [Abstract][Full Text] [Related]
2. In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors.
Blazar BA; Miller FR; Heppner GH
J Immunol; 1978 Jun; 120(6):1887-91. PubMed ID: 659883
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
Lopez DM; Sigel MM; Charyulu VL
J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
[TBL] [Abstract][Full Text] [Related]
4. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
Ruppert B; Blazar B; Medina D; Heppner G
J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
[TBL] [Abstract][Full Text] [Related]
5. Nonspecific T-cell reactivity in mice bearing autochthonous tumors or early-generation transplanted spontaneous mammary tumors.
Parthenais E; Haskill S
J Natl Cancer Inst; 1979 Jun; 62(6):1569-74. PubMed ID: 312353
[TBL] [Abstract][Full Text] [Related]
6. In situ lymphoid cells of mouse mammary tumors. II. The characterization of lymphoid cells separated from mouse mammary tumors.
Blazer BA; Heppner GH
J Immunol; 1978 Jun; 120(6):1881-6. PubMed ID: 659882
[TBL] [Abstract][Full Text] [Related]
7. Subset of spleen lymphocytes from BALB/cCrgl mice stimulated by mouse mammary tumor virus.
Lopez DM; Charyulu V; Sigel MM
Cancer Res; 1981 Mar; 41(3):813-8. PubMed ID: 6257384
[TBL] [Abstract][Full Text] [Related]
8. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
Buessow SC; Paul RD; Lopez DM
J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
[TBL] [Abstract][Full Text] [Related]
9. Retardation and promotion of growth of spontaneously appearing tumors using immune lymphocytes previously exposed to embryonic antigens.
Gorczynski RM; MacRae S
Cancer Res; 1982 Mar; 42(3):784-90. PubMed ID: 7059976
[TBL] [Abstract][Full Text] [Related]
10. Correlation of tumor growth and cell-mediated immune responses of mice bearing mammary tumors following surgical procedures.
Lopez DM; Sigel MM
J Reticuloendothel Soc; 1975 Nov; 18(5):305-12. PubMed ID: 1206665
[No Abstract] [Full Text] [Related]
11. In situ lymphoid cells of mouse mammary tumors. I. Development and evaluation of a method for the separation of lymphoid cells from mouse mammary tumors.
Blazar BA; Heppner GH
J Immunol; 1978 Jun; 120(6):1876-80. PubMed ID: 659881
[TBL] [Abstract][Full Text] [Related]
12. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
[TBL] [Abstract][Full Text] [Related]
13. Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor.
Miller BE; Miller FR; Leith J; Heppner GH
Cancer Res; 1980 Nov; 40(11):3977-81. PubMed ID: 7471048
[TBL] [Abstract][Full Text] [Related]
14. In vitro studies on the inhibitory effect of lymphoid cells. II. Antitumor activity of lymphoid cells from spontaneous mammary tumor-bearing mice on the autochthonous primary culture tumor cells.
Osugi M
Acta Med Okayama (1952); 1971 Aug; 25(4):229-35. PubMed ID: 4263557
[No Abstract] [Full Text] [Related]
15. Functionally sensitive and resistant populations of lymphoid cells from normal and mammary tumor bearing mice following treatment with cyclophosphamide.
Lopez DM; Paul RD; Gadgil AU; Lichter W
Anticancer Res; 1982; 2(4):227-33. PubMed ID: 7149652
[No Abstract] [Full Text] [Related]
16. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: rate of lymphoid infiltration and distribution of T lymphocytes in tumors.
Ben-Hur H; Kossoy G; Zandbank J; Zusman I
Int J Mol Med; 2002 Apr; 9(4):425-30. PubMed ID: 11891540
[TBL] [Abstract][Full Text] [Related]
17. Immunologic aspects of tumor induction by mammary tumor virus.
Blair PB
J Natl Cancer Inst; 1972 Apr; 48(4):1121-4. PubMed ID: 4336876
[No Abstract] [Full Text] [Related]
18. [Impairment of several forms of lymphocyte and hematopoietic stem cell interaction during tumor growth].
Khaitov RM; Gambarov SS; Petrov RV; Norimov ASh
Vopr Onkol; 1976; 22(3):49-54. PubMed ID: 945641
[TBL] [Abstract][Full Text] [Related]
19. Carbodiimide enhancement of complement-dependent antibody-mediated tumor cell lysis in vitro and antitumor activity in vivo.
Fawwaz RA; Tenforde TS; Mehlberg WH
Cancer Res; 1975 Mar; 35(3):679-86. PubMed ID: 1116128
[TBL] [Abstract][Full Text] [Related]
20. Interaction in culture between mouse ascites mammary carcinoma (MM2) cells and lymphoid cells of isologous mice.
Katsuta H; Ashikawa K; Takaoka T
Jpn J Exp Med; 1975 Jun; 45(3):223-9. PubMed ID: 1177362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
